SPDR S&P Biotech ETF
122 hedge funds and large institutions have $1.22B invested in SPDR S&P Biotech ETF in 2013 Q4 according to their latest regulatory filings, with 17 funds opening new positions, 44 increasing their positions, 39 reducing their positions, and 19 closing their positions.
Holders
122
Holders Change
-3
Holders Change %
-2.4%
% of All Funds
3.54%
Holding in Top 10
3
Holding in Top 10 Change
-2
Holding in Top 10 Change %
-40%
% of All Funds
0.09%
New
17
Increased
44
Reduced
39
Closed
19
Calls
$41.9M
Puts
$7.04M
Net Calls
+$34.8M
Net Calls Change
+$37.4M
Top Buyers
| 1 |
1
Morgan Stanley
New York
|
$176M |
| 2 |
2
Goldman Sachs
New York
|
$207M |
| 3 |
3
Citigroup
New York
|
$72.5M |
| 4 |
4
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
$20.1M |
| 5 |
5
Barclays
London,
United Kingdom
|
$36.4M |
